Nancy A. Dawson

13.9k total citations · 1 hit paper
145 papers, 4.3k citations indexed

About

Nancy A. Dawson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Nancy A. Dawson has authored 145 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 20 papers in Surgery. Recurrent topics in Nancy A. Dawson's work include Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Nancy A. Dawson is often cited by papers focused on Prostate Cancer Treatment and Research (86 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Nancy A. Dawson collaborates with scholars based in United States, United Kingdom and Canada. Nancy A. Dawson's co-authors include Nicholas J. Vogelzang, Eric J. Small, Susan Halabi, William J. Edenfield, John C. Byrd, David J. Shields, Ellen B. Kaplan, Philip W. Kantoff, Ellis Levine and Michael W. Kattan and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Nancy A. Dawson

138 papers receiving 4.2k citations

Hit Papers

Prognostic Model for Predicting Survival in Men With Horm... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer
    2003 541 citations Nancy A. Dawson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy A. Dawson United States 33 2.6k 1.3k 945 782 658 145 4.3k
Suneel Mundle United States 28 1.5k 0.6× 560 0.4× 913 1.0× 638 0.8× 1.3k 2.0× 131 3.3k
Simon Chowdhury United Kingdom 29 4.0k 1.6× 1.4k 1.0× 1.0k 1.1× 1.4k 1.8× 367 0.6× 199 5.1k
Przemyslaw Twardowski United States 29 2.4k 0.9× 2.2k 1.6× 1.6k 1.6× 1.2k 1.6× 238 0.4× 113 4.3k
Orazio Caffo Italy 36 2.0k 0.8× 2.4k 1.8× 1.4k 1.4× 1.4k 1.7× 202 0.3× 230 4.8k
Mary Ellen Taplin United States 16 4.2k 1.6× 1.6k 1.2× 924 1.0× 1.0k 1.3× 432 0.7× 27 5.1k
Tomomi Kamba Japan 27 1.2k 0.5× 1.0k 0.8× 1.3k 1.4× 635 0.8× 143 0.2× 152 3.3k
Roberto Iacovelli Italy 34 2.6k 1.0× 2.1k 1.6× 1.5k 1.6× 1.2k 1.6× 137 0.2× 224 4.6k
Stéphane Culine France 34 2.0k 0.8× 1.6k 1.2× 1.4k 1.4× 1.0k 1.3× 206 0.3× 163 4.6k
Matthew R. Smith United States 27 3.4k 1.3× 2.9k 2.2× 712 0.8× 872 1.1× 312 0.5× 72 5.4k
Jorge A. García United States 43 6.2k 2.4× 2.1k 1.6× 2.6k 2.7× 2.4k 3.1× 414 0.6× 213 8.1k

Countries citing papers authored by Nancy A. Dawson

Since Specialization
Citations

This map shows the geographic impact of Nancy A. Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy A. Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy A. Dawson more than expected).

Fields of papers citing papers by Nancy A. Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy A. Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy A. Dawson. The network helps show where Nancy A. Dawson may publish in the future.

Co-authorship network of co-authors of Nancy A. Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy A. Dawson. A scholar is included among the top collaborators of Nancy A. Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy A. Dawson. Nancy A. Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zwart, Alan, Dinesh Kumar, Paul Leger, et al.. (2024). Impact of neoadjuvant relugolix on patient-reported sexual function and bother. Frontiers in Oncology. 14. 1377103–1377103. 1 indexed citations
3.
Zwart, Alan, Deepak Kumar, Paul Leger, et al.. (2024). The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue. Frontiers in Oncology. 14. 1412786–1412786.
4.
5.
Xiao, Jerry, Alan Zwart, Thomas Yung, et al.. (2023). Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer. Frontiers in Oncology. 13. 1289249–1289249. 1 indexed citations
6.
Li, Zhuo, et al.. (2023). Patient Perception of Physician Attire Before and After the COVID-19 Global Pandemic Began. Journal of Patient Experience. 10. 672712491–672712491. 1 indexed citations
7.
Sholklapper, Tamir, Siyuan Lei, Abdul Rashid, et al.. (2023). Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes. Frontiers in Oncology. 13. 1240939–1240939. 1 indexed citations
8.
Sarker, Debashis, Nancy A. Dawson, Ana M. Aparicio, et al.. (2021). A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 27(19). 5248–5257. 22 indexed citations
9.
Dawson, Nancy A., Matthew R. Zibelman, Rebecca Feldman, et al.. (2020). An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer. Molecular Cancer Therapeutics. 19(6). 1373–1382. 19 indexed citations
10.
Atkins, Michael B., F. Stephen Hodi, John A. Thompson, et al.. (2018). Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study. Clinical Cancer Research. 24(8). 1805–1815. 48 indexed citations
11.
Dawson, Nancy A., et al.. (2014). Sipuleucel-T and immunotherapy in the treatment of prostate cancer. Expert Opinion on Biological Therapy. 14(5). 709–719. 8 indexed citations
12.
Moul, Judd W. & Nancy A. Dawson. (2012). Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature. Cancer Investigation. 30(1). 1–12. 20 indexed citations
13.
14.
Dawson, Nancy A., et al.. (2004). Update on hormone-refractory prostate cancer. Current Opinion in Urology. 14(3). 185–193. 27 indexed citations
15.
Dawson, Nancy A.. (2003). Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease. Expert Opinion on Pharmacotherapy. 4(5). 705–716. 11 indexed citations
16.
Dawson, Nancy A., William D. Figg, Michael R. Cooper, et al.. (1997). Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.. Journal of Clinical Oncology. 15(4). 1470–1477. 23 indexed citations
17.
Figg, William D., Nancy A. Dawson, Otis W. Brawley, et al.. (1996). Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer. Acta Oncologica. 35(6). 763–765. 8 indexed citations
18.
Figg, William D., Nancy A. Dawson, Oliver Sartor, et al.. (1996). A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response. Cancer Chemotherapy and Pharmacology. 39(1-2). 1–8. 34 indexed citations
19.
Dawson, Nancy A., Michael R. Cooper, William D. Figg, et al.. (1995). Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables. Cancer. 76(3). 453–462. 63 indexed citations
20.
Berger, Timothy G. & Nancy A. Dawson. (1988). Angioendotheliomatosis. Journal of the American Academy of Dermatology. 18(2). 407–412. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suneel Mundle Breakdown of academic impact, for papers by Simon Chowdhury Breakdown of academic impact, for papers by Przemyslaw Twardowski Breakdown of academic impact, for papers by Orazio Caffo Breakdown of academic impact, for papers by Mary Ellen Taplin Breakdown of academic impact, for papers by Tomomi Kamba Breakdown of academic impact, for papers by Roberto Iacovelli Breakdown of academic impact, for papers by Stéphane Culine Breakdown of academic impact, for papers by Matthew R. Smith Breakdown of academic impact, for papers by Jorge A. García
Rankless by CCL
2026